NO143460C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.

Info

Publication number
NO143460C
NO143460C NO752731A NO752731A NO143460C NO 143460 C NO143460 C NO 143460C NO 752731 A NO752731 A NO 752731A NO 752731 A NO752731 A NO 752731A NO 143460 C NO143460 C NO 143460C
Authority
NO
Norway
Prior art keywords
benzomorphanes
preparation
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO752731A
Other languages
English (en)
Other versions
NO143460B (no
NO752731L (no
Inventor
Herbert Merz
Adolf Langbein
Gerhard Walther
Klaus Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO752731L publication Critical patent/NO752731L/no
Publication of NO143460B publication Critical patent/NO143460B/no
Publication of NO143460C publication Critical patent/NO143460C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
NO752731A 1974-08-05 1975-08-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. NO143460C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (3)

Publication Number Publication Date
NO752731L NO752731L (no) 1976-02-06
NO143460B NO143460B (no) 1980-11-10
NO143460C true NO143460C (no) 1981-02-18

Family

ID=5922448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752731A NO143460C (no) 1974-08-05 1975-08-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.

Country Status (27)

Country Link
US (1) US3982005A (no)
JP (1) JPS60358B2 (no)
AT (1) AT348140B (no)
BE (1) BE832099R (no)
BG (3) BG25090A3 (no)
CA (1) CA1049008A (no)
CH (7) CH613963A5 (no)
CS (1) CS189717B2 (no)
DD (1) DD122685A5 (no)
DE (1) DE2437610A1 (no)
DK (1) DK138992C (no)
ES (6) ES452764A1 (no)
FI (1) FI63229C (no)
FR (1) FR2320096A2 (no)
GB (1) GB1513950A (no)
HU (1) HU177952B (no)
IE (1) IE42216B1 (no)
IL (1) IL47860A (no)
LU (1) LU73138A1 (no)
NL (1) NL7509249A (no)
NO (1) NO143460C (no)
PH (1) PH13687A (no)
PL (3) PL99816B1 (no)
RO (3) RO67390A (no)
SE (1) SE425392B (no)
SU (3) SU591147A3 (no)
ZA (1) ZA754997B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
US8329897B2 (en) 2007-07-26 2012-12-11 Vitae Pharmaceuticals, Inc. Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1
TW200927115A (en) 2007-11-16 2009-07-01 Boehringer Ingelheim Int Aryl-and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2254872A2 (en) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
WO2009134387A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723039A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR20110002492A (ko) 2008-05-01 2011-01-07 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
TW200950780A (en) 2008-05-13 2009-12-16 Boehringer Ingelheim Int Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AU2009274567B2 (en) 2008-07-25 2013-04-04 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
TWI531571B (zh) * 2009-11-06 2016-05-01 維它藥物公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜芳基羰基衍生物
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体
WO2022113437A1 (ja) 2020-11-26 2022-06-02 信越化学工業株式会社 室温硬化性オルガノポリシロキサン組成物及び物品並びに加水分解性オルガノシラン化合物及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (no) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166802B2 (no) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
PL99838B1 (pl) 1978-08-31
CH615680A5 (no) 1980-02-15
ES452768A1 (es) 1977-10-01
IL47860A (en) 1979-01-31
ES452763A1 (es) 1977-10-01
PL99816B1 (pl) 1978-08-31
JPS5139673A (en) 1976-04-02
DD122685A5 (no) 1976-10-20
RO72735A (ro) 1982-09-09
AU8364675A (en) 1977-02-10
SE7508789L (sv) 1976-02-10
ES452765A1 (es) 1977-10-16
DE2437610A1 (de) 1976-02-26
SU587858A3 (ru) 1978-01-05
AT348140B (de) 1979-01-25
HU177952B (en) 1982-02-28
DK138992C (da) 1979-04-30
FI752211A (no) 1976-02-06
CH613963A5 (no) 1979-10-31
NO143460B (no) 1980-11-10
NO752731L (no) 1976-02-06
FR2320096B2 (no) 1978-09-01
GB1513950A (en) 1978-06-14
CS189717B2 (en) 1979-04-30
BG25089A3 (en) 1978-07-12
US3982005A (en) 1976-09-21
ES452766A1 (es) 1977-10-01
FI63229C (fi) 1983-05-10
FI63229B (fi) 1983-01-31
IL47860A0 (en) 1975-11-25
ZA754997B (en) 1977-04-27
PL99819B1 (pl) 1978-08-31
ES452767A1 (es) 1977-10-01
CH615678A5 (no) 1980-02-15
BG25088A3 (en) 1978-07-12
RO72736A (ro) 1982-09-09
DK352875A (da) 1976-02-06
ES452764A1 (es) 1977-10-16
CA1049008A (en) 1979-02-20
SU591147A3 (ru) 1978-01-30
SU587859A3 (ru) 1978-01-05
CH616421A5 (no) 1980-03-31
DK138992B (da) 1978-11-27
CH615679A5 (no) 1980-02-15
JPS60358B2 (ja) 1985-01-07
CH615677A5 (no) 1980-02-15
IE42216B1 (en) 1980-07-02
LU73138A1 (no) 1977-04-13
BE832099R (fr) 1976-02-04
FR2320096A2 (fr) 1977-03-04
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
NL7509249A (nl) 1976-02-09
ATA523775A (de) 1978-06-15
BG25090A3 (en) 1978-07-12
IE42216L (en) 1976-02-05
SE425392B (sv) 1982-09-27
CH616420A5 (no) 1980-03-31

Similar Documents

Publication Publication Date Title
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
SE7507896L (sv) Inplanterbar anordning for forfarande for tillverkning av densamma.
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO144455C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater.
NO142173C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater
NO153573C (no) Analogifremgangsm¨te for fremstilling av terapeutisk aktiv e n-acylamino-alfa-arylacet-amidocefalosporiner.
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
NO141207C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater